Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
Ralph A Gruppo, MD |
Hemophilia And Thrombosis Center |
Cascade Hemophilia Consortium (Hemophilia Foundation of Michigan) |
Gruppo, CHC/HFM |
06/01/2003 - 05/31/2018 |
$114,597 |
Ralph A Gruppo, MD |
Community Counts: Public Health Surveillance for Bleeding Disorders |
Ctr for Disease Control and Prevention (Hemophilia Foundation of Michigan) |
10U27DD000862 |
10/01/1997 - 09/29/2016 |
$28,000 |
Lisa M Shook |
Sickle Treatment and Outcomes Research in the Midwest - Treatment Demonstration Project |
Health Resources & Services Admin |
U1EMC27863 |
09/01/2014 - 08/31/2017 |
$832,152 |
Russell Ware, MD, PhD |
Endothelialized Microfluidics for Sickle Cell Disease Research & Drug Discovery |
National Institutes of Health (Emory University) |
R01 HL121264 |
01/01/2014 - 12/31/2018 |
$18,372 |
Russell Ware, MD, PhD |
Genetic Modifiers of Transfusional Iron Overload |
National Institutes of Health (Baylor College of Medicine) |
R21HL123641 |
08/01/2015 - 07/31/2017 |
$17,979 |
Patrick McGann, MD, MS |
Therapeutic Response Evaluation and Adherence Trial: A Prospective Study of Hydroxyurea for Children with Sickle Cell Anemia |
National Institutes of Health |
K23 HL128885 |
09/01/2015 - 05/31/2020 |
$188,563 |
Joseph S Palumbo, MD |
Hemostatic Factors Drive Prostate Cancer Pathogenesis |
National Institutes of Health |
R01 CA193678 |
04/15/2016 - 03/31/2021 |
$356,850 |
Russell Ware, MD, PhD |
Genetic Variants Influencing the Phenotypic Expression of Sickle Cell Anemia |
Doris Duke Charitable Foundation |
2015132 |
09/01/2015 - 08/31/2018 |
$162,000 |
Joseph S Palumbo, MD |
Coagulation Factors as Modifiers of the Colon Cancer Microenvironment |
National Institutes of Health |
R01 CA204058 |
04/05/2016 - 03/31/2021 |
$356,850 |
Lisa M Shook |
Cincinnati Sickle Cell Project |
Ohio Department of Health |
0310011SK1017 |
07/01/2016 - 06/30/2021 |
$125,957.40 |
Harry Lesmana, MD |
Elucidating the Role of RalGDS Pathway in Erythropoiesis |
American Society of Hematology |
Lesmana, Harry, ASH |
07/01/2016 - 06/30/2017 |
$5,000 |
Patrick McGann, MD, MS |
Genetic and Biological Determinants of Immune Thrombocytopenia: ITP Consortium of North America (ICON) Research Sample Bank |
Texas Children's Hospital |
McGann, Pat, TCH |
07/01/2016 - 06/30/2020 |
$6,250 |
Russell Ware, MD, PhD |
Baby Hug Follow-up Study II Core Laboratory |
National Institutes of Health (New England Research Institutes) |
|
01/01/2016 - 05/05/2017 |
$266,950 |
Cristina Tarango, MD |
Region V East Comprehensive Care Network for Bleeding Disorders |
Maternal & Child Health Bureau (Hemophilia Foundation of Michigan) |
H30 MC24047 |
06/01/2016 - 05/31/2021 |
$22,000 |
Cristina Tarango, MD |
Community Counts: Public Health Surveillance for Bleeding Disorders |
Ctr for Disease Control and Prevention (Hemophilia Foundation of Michigan) |
U27 DD001155 |
09/30/2016 - 09/29/2020 |
$27,250 |
Cristina Tarango, MD |
Prospective Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) |
National Institutes of Health (All Childrens Research Inst., Inc.) |
U01 HL130048 |
01/11/2017 - 06/30/2021 |
$6,374 |
Adrienne Hammill, MD |
Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants with Infantile Hemangioma |
National Institutes of Health (Duke University) |
HHSN275201000003I |
01/01/2017 - 09/28/2017 |
$11,000 |
Cristina Tarango, MD |
ATHN Data Quality Counts |
American Thrombosis & Hemostatis Network |
AA108 |
07/01/2016 - 06/30/2017 |
$7,000 |
Adrienne Hammill, MD |
Phase 2 Study of Vincristine vs. Sirolimus for the Treatment of High Risk Kaposiform Hemangioendothelioma |
Food and Drug Administration (Children's Hospital Boston) |
R01 FD004363 |
09/01/2016 - 08/31/2017 |
$13,001 |
Cristina Tarango, MD |
Hemophilia Alliance Home Infusion Guidebook |
The Hemophilia Alliance Foundation |
Tarango, C, HAF |
03/01/2017 - 02/28/2018 |
$5,000 |
Total Annual Grant Award Dollars |
$2,571,145.40 |